Monday, March 5, 2018

SCIREQ INTRODUCES DRY POWDER DELIVERY AT SOT / TOXEXPO 2018

Many novel inhaled compounds and drugs require dry powder delivery and preclinical testing to assess efficacy and safety. The inExpose is an inhalation exposure system that provides a small-scale, configurable exposure for mice and rats studies.

Our recent addition of dry powder delivery expands the range of exposure environments beyond cigarette smoke, electronic cigarette vape, aerosols and gases.


The dry powder integration with the inExpose features:
          »   Up to 4 towers or chamber to be exposed simultaneously
          »   Identical or varying levels of exposure per tower or chamber
          »   Existing automation and control
          »   Small- scale exposure, minimizing compound use


Will you be attending the Society of Toxicology meeting in San Antonio next week? If so, I would like to invite you to come by booth #1545 to see our solutions for your preclinical respiratory research. We will be presenting a range of precise preclinical physiology solutions for safety pharmacology and toxicology studies, including:

          »   Automated, small-scale inhalation exposure studies featuring
               cigarettes, e-cigarettes, dry powders and aerosols
          »   Non-invasive tracking of ventilatory patterns and controlled gas exposure 
               with whole body plethysmography
          »   Continuous monitoring of physiological parameters with implantable and
               jacketed telemetry

Exhibit hours - Booth 1545
          Monday March 12 9:15am to 4:30pm
          Tuesday March 13 9:15am to 4:30pm
          Wednesday March 14         9:15am to 4:30pm

Click here to set-up a meeting to learn more about our solutions for your safety pharmacology and toxicology studies. 

If you are not planning to attend the conference but would like to receive additional information about our respiratory equipment, please contact our team of application specialists.

Looking forward to seeing you in San Antonio!

No comments:

Post a Comment